-transparent.png){kind=logo}
Clinical studies on apalcillin (APPC), a new broad spectrum semisynthetic penicillin developed in Japan, were carried out, and the following results were obtained. APPC was administered to three patients with serious biliary tract infections by intramuscular or intravenous injection at daily dosage of 2. Therapeutic responses were excellent in all cases, and no side effects and abnormalities of laboratory findings were observed. APPC was considered to be an excellent drug for the treatment of biliary tract infections.
Related Publications
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
March 1979,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
January 1977,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
May 1979,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
September 1979,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
February 1980,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
March 1976,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
June 1977,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
July 1981,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
March 1980,
The Japanese journal of antibiotics,
K Mishima, and
T Ohta, and
N Kitagawa, and
H Harada
June 1977,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
